Conference item
Baricitinib 4mg and 2mg once-daily reduced pain in both patients who were opioid users and non-users in active rheumatoid arthritis: a post-hoc analysis of phase 3 trials
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Authors
Bibliographic Details
- Publisher:
- Journal of Rheumatology Publisher's website
- Journal:
- Journal of Rheumatology Journal website
- Volume:
- 47
- Issue:
- 7
- Pages:
- 1129-1130
- Publication date:
- 2020-07-01
- DOI:
- EISSN:
-
1499-2752
- ISSN:
-
0315-162X
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1156651
- Local pid:
- pubs:1156651
- Deposit date:
- 2021-09-01
Terms of use
- Copyright holder:
- The Journal of Rheumatology Publishing Co. Ltd.
- Copyright date:
- 2020
- Rights statement:
- Copyright © 2020 by The Journal of Rheumatology Publishing Co. Ltd.
- Notes:
-
This is the accepted manuscript version of the article. The final version is available from Journal of Rheumatology at https://doi.org/10.3899/jrheum.200419
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record